FDA.reportPublic FDA data

Application 203129

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEXAMETHASONE SODIUM PHOSPHATEDEXAMETHASONE SODIUM PHOSPHATEINJECTABLE;INJECTIONEQ 4MG PHOSPHATE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
76045-106Dexamethasone Sodium PhosphateDexamethasone Sodium PhosphateFresenius Kabi USA, LLCANDACurrent
76045-106Dexamethasone Sodium PhosphateDexamethasone Sodium PhosphateFresenius Kabi USA, LLCANDACurrent
76045-106Dexamethasone Sodium PhosphateDexamethasone Sodium PhosphateFresenius Kabi USA, LLCANDACurrent
76045-106Dexamethasone Sodium PhosphateDexamethasone Sodium PhosphateFresenius Kabi USA, LLCANDACurrent
76045-210Dexamethasone Sodium PhosphateDexamethasone Sodium PhosphateFresenius Kabi USA, LLCANDACurrent